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Incidence and Associations of Hemiplegic Shoulder Pain Post Stroke:  1 
A prospective population based study  2 
 3 
Abstract 4 
 5 
 6 
Objective: To provide an epidemiological perspective of the clinical profile, frequency and 7 
determinants of post stroke hemiplegic shoulder pain.  8 
 9 
Design:  A prospective population-based study of an inception cohort of participants with 12 10 
months follow up period.   11 
 12 
Participants: Multiple ascertainment techniques were used to identify 318 confirmed stroke 13 
events in 301 individuals. Among 301 adults with stroke, data on shoulder pain were 14 
available for 198 (83% of survivors) at baseline, and 156 and 148 at 4 and 12 months, 15 
respectively.   16 
 17 
Setting: Participants were recruited within a geographically defined metropolitan region with 18 
estimated population of 148,000 in Adelaide, Australia.  Ascertainment and follow up 19 
included both general community and hospital settings.   20 
 21 
Interventions: not applicable 22 
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 23 
Main Outcome Measures: Subjective reports of onset, severity and aggravating factors for 24 
pain, and three passive range of motion measures were collected at baseline, and follow-up at 25 
4 and 12 months.   26 
 27 
Results: 10% of participants reported shoulder pain at baseline, whilst 21% reported pain at 28 
each follow-up assessment.  Overall, 29% of all assessed participants reported shoulder pain 29 
during 12 months follow up, with the median pain score (VAS = 40) highest at 4 months and 30 
more often associated with movement at later time points.  Objective passive range of motion 31 
tests elicited higher frequencies of pain than self-report, and predicted later subjective 32 
shoulder pain (crude relative risk of 3.22 (95%CI 1.01-10.27). 33 
 34 
Conclusions:  The frequency of post-stroke shoulder pain is almost 30%.  Peak onset and 35 
severity of hemiplegic shoulder pain in this study was at 4 months, outside of rehabilitation 36 
admission timeframes.  Systematic use of objective assessment tools may aid in early 37 
identification and management of stroke survivors at risk of this common complication of 38 
stroke. 39 
 40 
Key Words (3-7):  41 
Stroke, epidemiology, hemiplegia, shoulder, pain 42 
 43 
List of Abbreviations: 44 
VAS  Visual Analogue Scale 45 
3 
 
CI  Confidence Interval 46 
LACS  Lacunar Syndrome 47 
TACS  Total Anterior Circulation Syndrome 48 
PACS  Partial Anterior Circulation Syndrome 49 
POCS  Posterior Circulation Syndrome 50 
NIHSS  National Institute of Health Stroke Scale 51 
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Hemiplegic shoulder pain has been described as one of the four most common medical 57 
complications following stroke1, with others including depression, falls and urinary tract 58 
infections1.  Earlier studies have reported the frequency of shoulder pain following stroke to 59 
be as high at 65-70%2-4.  A more recent prospective Swedish study of 416 consecutive stroke 60 
patients reported that almost a third of stroke survivors developed shoulder pain, the majority 61 
of whom reported moderate to severe pain5.  Contributions to pain development are often 62 
multifactorial; biomechanical factors are significant6, and may occur in isolation or in 63 
addition to changes in tone7 or neuropathic mechanisms8.   Hemiplegic shoulder pain is 64 
associated with a reduction in functional use of the arm9, interference with rehabilitation9, 65 
increased length of stay9 and higher rates of depression10.  Complexities in aetiology and 66 
subsequent diagnosis mean that treatment of shoulder pain is difficult and reviews have found 67 
little evidence to guide clinicians on effective prophylactic and treatment options11.  68 
Understanding the pattern of presentation, and establishing tools to support early 69 
identification of those likely to develop pain would assist clinicians and patients.  70 
 71 
The primary aim of this study was to determine the frequency, characteristics over time, and 72 
associations of hemiplegic shoulder pain in a defined metropolitan population of South 73 
Australia.  The secondary aim was to evaluate the predictive use of three standardised passive 74 
objective measures of shoulder range as screening tools for development of shoulder pain.  75 
Objective assessment is necessary in conjunction with subjective questioning, as self-report 76 
alone has been shown to be a poor predictor of examination findings6, and accurate clinical 77 
assessment and diagnosis is vital in establishing targeted management plans.  A case control 78 
study suggested that a simple set of clinical assessments (three passive range of motion tests) 79 
conferred a 98% probability of predicting early hemiplegic shoulder pain at rest12.  The 80 
generalizability of this finding is limited due to its small sample with multiple exclusion 81 
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criteria (thalamic infarcts, upper limb sensory deficit, previous shoulder injury, complex 82 
regional pain syndrome, dysphasia).  We evaluated this same set of assessments on all 83 
participants in a stroke incidence study, based on the principles of complete ascertainment13, 84 
to test their application as a predictor of development of hemiplegic shoulder pain.  85 
 86 
Methods 87 
 88 
Overview 89 
 90 
The Adelaide stroke incidence study (ASCEND) was a prospective population-based stroke 91 
incidence study conducted in a defined region of the western suburbs of Adelaide, South 92 
Australia, with a census projected population of over 148,000.  During the period from 15 93 
July 2009 to 15 July 2010, multiple ascertainment methods were used to identify all 94 
occurrences of stroke.  Ethics approval was obtained from every tertiary hospital in Adelaide 95 
and University of Adelaide and all participants provided consent prior to enrolment in the 96 
study.  Detailed methodology has been previously described14, including specific information 97 
regarding the study population and ascertainment techniques. 98 
 99 
Following informed consent, participants were assessed at baseline, at 4 months and at 12 100 
months.  All data were collected as part of the larger ASCEND study and entered into a 101 
custom-designed online database.  The data set specific to this study was extracted via an 102 
automated database query and checked against the raw database manually.  Only data that 103 
were truly prospective were included for analyses, as retrospective report of subjective pain 104 
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measures was not deemed reliable and retrospective case note data would not include the 105 
objective tests.   106 
 107 
Definitions 108 
 109 
Stroke was defined as “rapidly developing clinical signs of focal (or global) disturbance of 110 
cerebral function lasting more than 24 hours (unless interrupted by surgery or death) with no 111 
apparent cause other than of vascular origin”15.  Hemiplegic shoulder pain was defined as any 112 
subjective complaint of pain in the contralesional, or affected hemiplegic shoulder following 113 
stroke.  Hemiplegic shoulder pain encompasses all aetiologies and we did not exclude 114 
patients on the basis of premorbid shoulder pathology.  Pain was measured using a Visual 115 
Analogue Scale (VAS range 0-100) with severity classified into mild (10-30) and moderate-116 
severe (40-100) in line with previous publications16, 17.  Upper limb motor function was 117 
determined using question 5 from the NIHSS – motor arm score of 3 or above was classified 118 
as ‘no motor function’ (score 3 = no effort against gravity; score 4 = no movement), and 119 
reduced motor function was score 1-2 (score 1 = drift; score 2 = limited effort against 120 
gravity). 121 
 122 
Demographic Data, Subjective and Objective Assessments 123 
 124 
The subset of data of interest in the study included record of demographic data, and baseline 125 
and follow up subjective and objective measures pertaining specifically to shoulder pain.   126 
Demographic and clinical characteristics were recorded to characterise the subsets within the 127 
study population and to explore any associations with risk of development of shoulder pain.  128 
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Data included age, gender, significant medical history, stroke subtype and aetiology, affected 129 
hemisphere, and motor arm component of the National Institute of Health Stroke Scale 130 
(NIHSS). 131 
Subjective information included history of shoulder pain prior to stroke and presence of 132 
shoulder pain on affected side.  If pain was reported, further questions regarding time of 133 
onset, severity of pain, and aggravating factors were asked.  Patients were asked if pain was 134 
worse at rest, on movement (active or passive), or at night.  Pain severity was scored using a 135 
vertical VAS.  Each consented participant was assessed by a trained study nurse.   136 
A rehabilitation physician taught all data collectors a standardised approach to objective tests, 137 
and a video support package was made and provided for ongoing reference.   138 
Objective measures of the participants’ affected upper limb included:  139 
• the modified Neer test (forced passive forward flexion) tested in a seated position 140 
• passive Hand-Behind-Neck test (passive abduction, external rotation) tested in a 141 
seated position, and  142 
• passive external rotation as compared to unaffected limb.  Passive external rotation 143 
was measured with the patient in a seated position.  Range was measured using a 144 
goniometer. 145 
Any pain on modified Neer or passive hand-behind-neck was scored as a positive result.  146 
Affected limb passive external rotation range of more than 10º less than the unaffected 147 
limb was scored as positive limitation of range of movement.    148 
 149 
Statistical Analysis 150 
 151 
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Comparisons were made of baseline demographics for participants with and without shoulder 152 
pain using Wilcoxon tests for continuous variables or chi-squared tests for categorical 153 
variables.  Non-parametric tests (i.e. Wilcoxon or Kruskal-Wallis tests) were selected in the 154 
context of analysis of continuous variables because some variables (such as VAS and 155 
NIHSS) had skewed distribution.  The primary outcome was onset of shoulder pain within 156 
the first year of stroke onset.  Measures of shoulder function (subjective report of pain, pain 157 
severity, aggravating factors, and objective assessments) at each visit were compared using 158 
Kruskal-Wallis or chi-squared tests.  Associations between baseline demographic subsets and 159 
development of shoulder pain were assessed using logistic regression models and statistically 160 
significant predictors were included into multivariable logistic regression models.  Data are 161 
reported with the standard level of significance (P <0.05) and with 95% confidence intervals 162 
(CI).  All analyses were performed using SAS software version 9.2 (Cary, NC, USA). 163 
 164 
Results 165 
 166 
 167 
As some participants had more than one stroke event, a total of 318 strokes were confirmed 168 
in 301 people in the study population. Excluded were 103 people without a shoulder 169 
assessment due to death (60%), retrospective ascertainment (12%), or non-consent to 170 
participation (28%) (see Figure 1).  For baseline assessments, 73% of all recruited patients 171 
were assessed within one week of symptoms onset14 (average 8.7 days post onset).  At 172 
baseline, a shoulder assessment was completed on 198 (83%) of 239 survivors, 156 (75%) at 173 
4 months, and 148 (77%) at 12 months.  A total of 226 shoulder assessments were performed 174 
at any assessment point within the follow-up period, with complete data from all 3 time 175 
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points available for 105 participants surviving to 12 month follow-up.  Among survivors, 176 
baseline characteristics were comparable between participants with and without pain, except 177 
severity of upper limb deficits and history of premorbid shoulder pain which were 178 
significantly greater in those participants reporting subjective pain (Table 1).  The 179 
demographic and clinical variables of participants receiving shoulder assessment as compared 180 
to those not receiving any assessment are summarised in Supplementary data Table I.  In the 181 
group who did not receive a shoulder assessment, there were significantly more haemorrhagic 182 
strokes (25% versus 9%) and Total Anterior Circulation Syndrome (TACS) strokes (67% 183 
versus 18%), reflecting higher mortality from more severe strokes.  Data from patients who 184 
did not receive shoulder assessment were excluded from further analysis.  185 
 186 
Table 2 summarises the incidence of shoulder pain over 12 months.  Comparison of 187 
participants receiving any assessment (n=226) to participants receiving assessments at all 188 
time points (n=105) demonstrated similar frequencies at each follow up, with a clear pattern 189 
of increasing frequency of pain over 12 months.  Of stroke survivors receiving any 190 
assessment, 10% reported pain at baseline and 21% at each follow up period.  Overall, 191 
approximately one third (65/226=29%) of individual participants reported onset of shoulder 192 
pain within the 12 months following their stroke.  In the cohort of participants receiving 193 
shoulder assessment at all three time points (n=105), Figure 2 shows that shoulder pain 194 
increased in frequency over time: 8% at baseline, 18% at 4 months, and 21% at 12 months   195 
A relatively low rate of pain resolution at each time point is demonstrated (6% at 4 months 196 
and 14% at 12 months respectively).   197 
 198 
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Subjective reports of severity and factors aggravating hemiplegic shoulder pain amongst 199 
participants receiving any assessment are summarised in Table 3.  The median pain score 200 
(VAS = 40) was highest at 4 months.  Pain characteristics in the early weeks demonstrated 201 
milder pain (median VAS = 15) which was more prominent at rest (including night).  At 202 
follow up, pain was shown to be more associated with limited active and passive range of 203 
movement and significantly fewer participants reported pain which was worse at rest or at 204 
night (Figure 3).   205 
 206 
Crude and multivariable analysis found a strong association between premorbid shoulder pain 207 
and post-stroke hemiplegic shoulder pain (Table 4).  Additionally, an absence of upper limb 208 
motor function was strongly associated with risk of shoulder pain (OR 3.19 (1.77-6.9) 209 
p=0.0003).  The odds ratio (CI 95%) for pain associated with reduced arm function was 1.24 210 
(0.7-2.17) p=0.458.  A large proportion (86%) of participants with TACS strokes died before 211 
the baseline assessment.  There was no association of shoulder pain and basic demographics, 212 
stroke syndrome, affected hemisphere, or stroke severity.   213 
 214 
In stroke survivors who reported pain at baseline, baseline passive range of motion tests were 215 
not consistently positive (not all patients reporting pain had positive objective tests).  Follow-216 
up assessments demonstrated increasing frequency of positive objective tests in those with 217 
reported pain, and objective passive range of motion tests were associated with higher 218 
frequencies of pain than were elicited by self-report alone.  Further evaluation revealed that 219 
positive baseline objective assessments, despite the absence of subjectively reported pain, 220 
conferred a statistically significant crude relative risk of 3.22 (95% CI 1.01 to 10.27) for 221 
future development of hemiplegic shoulder pain within a 12 month period.  Multivariate 222 
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analysis, adjusting for high NIHSS score (>5 above median) and significant motor upper limb 223 
deficit, demonstrated an odds ratio of 2.13 (CI 0.54 to 8.35) although this was not significant 224 
(Table 5). 225 
 226 
Discussion  227 
In a field in need of greater research focus, this study contributes data on early incidence of 228 
pain and pain characteristics in the first year post stroke.  Additionally, the study supports the 229 
predictive value of easily reproducible objective screening tests. 230 
 231 
This study found that approximately one third of stroke survivors experienced shoulder pain 232 
at some stage in the 12 months post stroke, with peak incidence of pain at 4 months.    233 
Congruous data in studies of comparable methodology2, 5, 18 lend weight to this finding 234 
regarding rate of shoulder pain (previous papers reported rates as high as 70%)2, 19, 20.  A 235 
pertinent issue to consider, in the context of persistently significant rates of hemiplegic 236 
shoulder pain, is the possibility that this may reflect a lack of improved prevention measures 237 
regarding education and shoulder care over more recent years.  Thus, despite previous studies 238 
highlighting the amplitude of this issue, it is postulated that minimal gains in evidence-based 239 
treatment and prevention options, or translation of the same into practice are indicated.   240 
 241 
A novel finding of our study is the comparatively low frequency of very early (average 8.7 242 
days) hemiplegic shoulder pain (10%).  Lindgren et al5 followed up 416 people from a Stroke 243 
Register, with specific study pain questions and assessment at 4 and 16 months; at follow up I 244 
(4 months), almost 40% of participants reported that their pain begun between 0-2 weeks post 245 
stroke.  In the current study, prospective data regarding baseline pain were collected.  246 
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Interestingly, patients who reported pain within the first few days following stroke were not 247 
necessarily those who went on to have persistent pain complaints.  There was a much higher 248 
rate of new onset pain at 4 month follow-up compared to pain persisting from baseline 249 
assessment, highlighting the need for ongoing monitoring after hospital discharge.  A 250 
relatively low rate of pain resolution at each time point was demonstrated (6% at 4 months 251 
and 14% at 12 months respectively), further indicating the need to establish an increased pool 252 
of effective evidence-based treatment options. The increasing association of pain with range 253 
of movement (active and passive) over time may represent cumulative musculoskeletal 254 
contributors and adaptive mechanisms, with pain on movement recognised as one of the 255 
cardinal features of musculoskeletal pain21.  Mechanisms of pain may differ and additional 256 
research exploring evidence-based treatment options that address early versus later onset 257 
hemiplegic shoulder pain are needed.   258 
 259 
The predominant associations between clinical profile and risk of shoulder pain were in 260 
participants with premorbid pain and those with more marked upper limb motor deficit.  261 
Whilst previous population-based studies5 have found motor deficit to be predictive, they 262 
have not demonstrated premorbid shoulder pain as a risk factor for developing pain.  In this 263 
study, history of shoulder pain was reported in 27% of participants with hemiplegic shoulder 264 
pain, compared to only 4% of those who did not report pain.  This differs from Lindgren et 265 
al5, who found similar rates of premorbid shoulder pain reported by those who subsequently 266 
developed pain and those who did not (23% versus 22% respectively).  Pain history is a 267 
simple question easily added to clinical screening assessment battery and further helps 268 
identify an at-risk cohort.   269 
 270 
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The association of compromised range of motion with persistent pain is supported by recent 271 
studies.  Research supports that persistent pain is more likely in patients with left sided 272 
weakness22, and in those who demonstrate reduced passive abduction range22, 23, as well as 273 
patients with reduced external rotation range, impaired voluntary motor control and 274 
spasticity22, 23.  We did not find an association between affected hemisphere and pain 275 
development, but our data does support the previous findings that pain is associated with 276 
reduced passive abduction and external rotation (passive hand-behind-neck and external 277 
rotation tests respectively), and impaired motor function.  Testing of passive range is often 278 
impacted by increasing tone, though formal spasticity assessment was not included in this 279 
study.   280 
 281 
With the three passive range of motion tests used, it was possible to identify those likely to 282 
develop pain.  Those patients who demonstrated a positive response on an objective passive 283 
range of movement test at baseline trended to be at increased risk of later pain, suggesting 284 
that these tests may serve a useful screen among at-risk patients, namely those with more 285 
severe upper limb paresis.  Rajaratnam12 proposed use of all three tests to identify those at 286 
risk of early pain at rest.  Results from this study support use of these tests as a screening tool 287 
beyond the early phase, with evidence that positive objective results double a patient’s 288 
probability of developing future hemiplegic shoulder pain.  At both follow up points, the 289 
passive external rotation test and modified Neer test recorded greater number of positive 290 
results than the passive hand-behind-neck.  Passive external rotation findings on follow up 291 
were greater than subjective report of pain alone (21% reported pain at 4 months, 25% 292 
recorded positive external rotation test; 21% reported pain at 12 months, 22% recorded 293 
positive passive external rotation test).   Remaining objective tests did not provide results 294 
higher than subjective pain result, but it must be considered that the variety of movements 295 
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covered by the use of all three of these tests provides a more thorough screening tool.  The 296 
tests used are simple to perform, easy to teach in a reproducible manner, and time and cost 297 
efficient in the context of incorporation into standardised protocols.  Whilst it is well 298 
established that transfer of evidence into clinical practice is significantly delayed, the use of 299 
such a simple screening assessment can be hoped to be easily implemented within a field of 300 
medicine at ease with joint assessment and manual handling. 301 
 302 
The use of screening assessments should not replace more in-depth diagnostic assessments of 303 
patients with verified hemiplegic shoulder pain.  The increasing body of research exploring 304 
the contribution and overlap of neuropathic as well as nociceptive pain mechanisms8, 23, 24 305 
highlights the importance of careful assessment beyond the musculoskeletal paradigm 306 
covered by the outlined objective measures.  As such, the assessment outlined is supported as 307 
a screening tool, rather than a diagnostic tool.  More in depth assessment is required to 308 
ascertain potential contributors to active pain, and should consider specific spasticity 309 
measures and comprehensive pain history.    Screening in this study is perhaps of more utility 310 
to identify those not subjectively reporting pain at rest but potentially experiencing pain with 311 
range of movements beyond their active range.  The data supports that positive objective tests 312 
double the risk of future development of pain.  It must also be highlighted that the paucity of 313 
evidence-based treatment options currently available means that successful screening does 314 
not yet yield significant benefit to the patient group.  A focus on effective treatment options is 315 
required in order to make best use of screening within an assessment and management 316 
protocol. 317 
 318 
Study Limitations: 319 
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 320 
The study was limited by some loss of patient data due to early death or delay in 321 
ascertainment which reduced the ability to achieve timely or prospective assessment.  As 322 
highlighted in the parent study14, ascertainment may have been incomplete despite intensive 323 
efforts.  In addition, there was variable loss of data at the follow up assessments.  Finally, we 324 
did not account for spasticity in our assessments, which could have affected passive range 325 
and pain reports. 326 
Strengths of our study include the use of ‘ideal’ methodology13 to avoid selection bias and the 327 
prospective assessments available for analyses.   328 
 329 
Conclusion: 330 
 331 
Close to 30% of people develop pain in the first year after stroke, with peak incidence at 4 332 
months.  Comparison with an earlier population study5 shows that, despite increased focus on 333 
evidence-based treatments in stroke, over 7 years no reduction in frequency of this common 334 
complication stroke has been shown.  Systematic use of clinical assessments are useful in 335 
identifying people at risk of shoulder pain.  As the disorder is most common and severe after 336 
hospital discharge, targeted protocols including predictive objective measures may facilitate 337 
improved identification and management.  Further research is required to elucidate a practical 338 
range of preventative and treatment options for this condition. 339 
 340 
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Figure Legend: 422 
 423 
Figure 2: Frequency of Hemiplegic Shoulder Pain 424 
 425 
 426 
 427 
Figure 3: Factors aggravating shoulder pain over 12 months 428 
429 
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